Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tecfidera
Pharma
Biogen CEO plots turnaround after 'weak' 2023 performance
While Biogen’s financials are in rough shape now, the company’s CEO, Chris Viebacher, sees reason to be optimistic about the future.
Fraiser Kansteiner
Feb 13, 2024 11:28am
Biogen notches another Tecfidera patent win in Europe
Dec 19, 2023 9:30am
Biogen scores a Tecfidera patent win in Europe
May 5, 2023 11:02am
TG Therapeutics wins green light for MS antibody Briumvi
Dec 29, 2022 9:46am
Biogen's push to regain Tecfidera patent swatted down by SCOTUS
Oct 3, 2022 11:13am
Biogen pays $900M to resolve whistleblower's kickbacks suit
Jul 20, 2022 10:30am